What is it about?
This article provides new insights into the importance of FN1 in cartilage tissue engineering to encourage more studies concerning FN1 in cartilage repair studies. Further, we provided new suggestions for advanced applications of FN1 to treat OA and cartilage degeneration.
Featured Image
Photo by Anne Nygård on Unsplash
Why is it important?
Few studies reported the potential of FN1 to enhance tissue engineering and reduce the death of chondrocytes in OA. Further, FN1 possesses multiple binding domains including collagen, integrin, and heparin that can interact with heparan sulfate proteoglycans at the surface of chondrocytes leading to promoting cell signaling and differentiation.
Perspectives
Presents a new opportunity for using FN1 in clinical trials
Dr Murad Alahdal
Johns Hopkins University
Read the Original
This page is a summary of: Insights into the implementation of Fibronectin 1 in the cartilage tissue engineering, Biomedicine & Pharmacotherapy, April 2022, Elsevier,
DOI: 10.1016/j.biopha.2022.112782.
You can read the full text:
Contributors
The following have contributed to this page
